RazorMetrics, a leading innovator in pharmacy cost management, announced that it has generated over $11 million in prescription drug savings for health plans and residents across Ohio. These savings impacted nearly 60,000 covered members and highlight RazorMetrics’ ongoing ability to reduce drug spending while ensuring access to necessary medications. Rising prescription costs continue to challenge employers, health plans, and public programs nationwide. RazorMetrics addresses avoidable pharmacy waste by identifying duplicative therapies, excess supply, and opportunities to switch to clinically appropriate lower-cost alternatives, all within existing prescriber workflows.
Health Technology Insights: MHK Launches SmartProminence AI Solutions
Dr. Siva Mohan, Chief Medical Officer and President of RazorMetrics, said that inefficiencies in prescribing and pharmacy processes often make medications more expensive than necessary. He explained that RazorMetrics helps physicians recognize opportunities to reduce costs without affecting patient care. The platform integrates directly into clinical workflows to support deprescribing, medication switching, deduplication, and use of biosimilars, all aligned with plan designs and formulary preferences. This method allows plans to achieve meaningful savings while maintaining trust with providers and members.
Health Technology Insights: Artera Secures $65Million Growth Investment and Reaches $100Million CARR
Tom Dorsett, CEO of RazorMetrics, said that Ohio plans and employers want solutions that provide measurable results without disrupting care. He noted that these savings demonstrate how addressing waste within the pharmacy benefit can reduce costs without shifting risk or complexity onto members. After achieving strong outcomes in Texas, Ohio became the next logical market for RazorMetrics, and the company continues to explore other states where its approach can deliver similar results.
In 2025, RazorMetrics reported $34 million in prescription drug savings for over 1.1 million members in Texas over a two-year period, illustrating the significant impact of reducing pharmacy waste within prescriber workflows. The company’s active network includes more than 525,000 prescribers across the United States and Puerto Rico. The results in Ohio further confirm that RazorMetrics’ approach can consistently deliver meaningful savings across various plan types, populations, and state markets.
Following a year of strong growth, RazorMetrics earned recognition for innovation and expansion, ranking No. 18 on the Inc. 5000 list and No. 12 on Deloitte’s Technology Fast 500, with top placements in life sciences at both state and national levels. As the company enters 2026, its focus remains on expanding its clinically aligned pharmacy cost management approach to help plans improve affordability and medication safety on a larger scale.
Health Technology Insights: First Stop Health Joins ParetoHealth Network
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
